Loading...

GeneDx Holdings Corp.

WGS•NASDAQ
Healthcare
Medical - Healthcare Information Services
$68.53
$2.29(3.46%)
U.S. Market opens in 44h 13m

GeneDx Holdings Corp. (WGS) Stock Overview

Explore GeneDx Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-87.98
EPS (TTM)$-0.73
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$88.48
3 Months$106.25
1 Year Target$180.00

WGS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GeneDx Holdings Corp. (WGS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.21, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $180.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -87.98 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.46%
5-Day Change
1.60%
1-Month Change
-0.20%
3-Month Change
-32.38%
6-Month Change
-46.82%
Year-to-Date (YTD) Change
-47.31%
1-Year Change
-37.35%
3-Year Change
613.85%
5-Year Change
-85.39%
All-Time (Max) Change
-78.81%

Contact Information

http://www.genedx.com
800 298 6470
North Tower, Stamford, CT, 06902

Company Facts

10,000 Employees
IPO DateNov 4, 2020
CountryUS
Actively Trading

Frequently Asked Questions